Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare

Table 1

Patient characteristics. Early transplants are those from 2000 to 2003, while late transplants are between 2004 and 2007.

	Early		Late
Patient characteristics	, (%)		, (%)
Female	45 ()		64 ()
White	97 ()		145 (91)
Age, median (range)	70 (66–92)		70 (66–90)
66–70	75 ()		100 (63)
70–74	21 ()		47 ()
75+	14 ()		13 ()
Charlson Comorbidity Index
0	68 (62)		101 (63)
1	29 ()		37 ()
2+	13 ()		22 ()
Survival outcomes	CCI0	CCI1+	CCI0	CCI1+
100 days	95%	85%	99%	93%
1 year	90%	76%	92%	86%
3 years	62%	42%	66%	66%
Cost outcomes; Median (25%; 75%)	CCI0	CCI1+	CCI0	CCI1+
100 days	70,900; (46,000; 85,200)	72,000; (55,600; 81,100)	58,400; (37,900; 73,900)	60,400; (50,300; 70,100)
1 year	86,100; (59,500; 113,100)	98,300; (75,100; 116,700)	81,300; (59,400; 112,300)	77,700; (69,300; 91,800)
3 years	139,200; (94,200; 179,900)	195,300; (153,300; 224,600)	124,400; (97,300; 159,500)	110,900; (89,600; 167,300)

Early , late . Early , late . Early , late .